Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition

  • Hanadi Ajam Oughli
  • , Marie Anne Gebara
  • , Adam Ciarleglio
  • , Helen Lavretsky
  • , Patrick J. Brown
  • , Alastair J. Flint
  • , Nuri B. Farber
  • , Jordan F. Karp
  • , Benoit H. Mulsant
  • , Charles F. Reynolds
  • , Steven P. Roose
  • , Lei Yang
  • , Meryl A. Butters
  • , Eric J. Lenze

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience